Gainers
- Better Therapeutics (NASDAQ:BTTX) stock increased by 9.9% to $2.21 during Monday's after-market session. Today's trading volume for this security ended up closing at 13.8 million shares, which is 7970.9 percent of its average volume over the last 100 days. The company's market cap stands at $52.1 million.
- Unicycive Therapeutics (NASDAQ:UNCY) shares moved upwards by 8.04% to $0.94. The company's market cap stands at $14.1 million.
- Achilles Therapeutics (NASDAQ:ACHL) stock moved upwards by 7.69% to $2.38. The company's market cap stands at $92.7 million.
- Athenex (NASDAQ:ATNX) stock rose 7.46% to $0.54. The market value of their outstanding shares is at $59.6 million.
- AcelRx Pharmaceuticals (NASDAQ:ACRX) stock increased by 6.47% to $0.26. The market value of their outstanding shares is at $38.1 million.
- TC BioPharm (Holdings) (NASDAQ:TCBP) shares moved upwards by 5.46% to $1.35. The company's market cap stands at $37.8 million.
Losers
- Forward Pharma (NASDAQ:FWP) shares fell 17.6% to $4.7 during Monday's after-market session. The company's market cap stands at $33.3 million.
- Semler Scientific (NASDAQ:SMLR) shares declined by 9.79% to $42.7. The market value of their outstanding shares is at $289.4 million. The company's, Q1 earnings came out today.
- Shattuck Labs (NASDAQ:STTK) stock decreased by 8.63% to $3.6. The company's market cap stands at $152.5 million.
- Alaunos Therapeutics (NASDAQ:TCRT) stock declined by 7.8% to $0.45. At the close, Alaunos Therapeutics's trading volume reached 669.5K shares. This is 29.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $98.1 million.
- IGM Biosciences (NASDAQ:IGMS) shares decreased by 7.02% to $17.76. The market value of their outstanding shares is at $778.4 million.
- Bluejay Diagnostics (NASDAQ:BJDX) shares fell 6.76% to $1.38. Bluejay Diagnostics's trading volume hit 88.4K shares by close, accounting for 21.0% of its average volume over the last 100 days. The company's market cap stands at $27.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
